Lung cancer grant opportunity from The CHEST Foundation
Today #LCSM received the following information about a lung cancer grant opportunity from The CHEST Foundation (the philanthropic arm of the American College of Chest Physicians). We’re sharing it here to encourage more participation in lung cancer research. ————————— The CHEST Foundation has been supporting lung cancer research since 2002, and this award, established in 2011, funds much needed research that leads to improved treatment and/or a cure for lung cancer. The grant recipient will receive $100,000 in payments of $50,000 each year for 2 years. Eligibility criteria and the application are… Read More
#LCSM Chat Topic 4/10: “Exercise During and After Lung Cancer Treatment”
The next #LCSM Chat will occur Thursday April 10 at 8 PM EDT (5 PM PDT) and will focus on “Exercise During and After Lung Cancer Treatment.” Our moderator will be Janet Freeman-Daily. Exercise is known to improve quality of life and reduce recovery time, fatigue, sleep issues and depression in cancer patients. A recent study indicates high-intensity exercise during cancer treatment can have many benefits. Some facilities now offer pulmonary rehabilitation after lung cancer treatment to help patients recover lung capacity more quickly. Others offer fitness classes that adapt a fitness… Read More
Upcoming #LCSM Chat, Thursday, March 27 at 5 pm PT, 8 pm ET: Should All Targeted Rx Lung Cancer Trials be Biomarker-Selective?
ASCO, the American Society for Clinical Oncology, is promoting a new principle that targeted therapies should be used only in targeted patients, as part of a general trend that we need to move away from trials that test new non-chemotherapy agents in a broad population. Meanwhile, we’ve just recently seen a few high profile negative trials in the last few weeks, such as the large phase III METLung trial of “METMAb” or onartuzumab, the monoclonal antibody against the target MET (mesenchymal epithelial transition), combined with Tarceva (erlotinib), and also the MAGE-A3 vaccine… Read More
#LCSM 
You must be logged in to post a comment.